Persistent URL of this record https://hdl.handle.net/1887/107907
In Collections
This item can be found in the following collections:
Beneficial Effects of the mTOR Inhibitor Everolimus in Patients with Advanced Medullary Thyroid Carcinoma: Subgroup Results of a Phase II Trial
- All authors
- Schneider, T.C.; Wit, D. de; Links, T.P.; Erp, N.P. van; Hoeven, J.J.M. van der; Gelderblom, H.; Wezel, T. van; Eijk, R. van; Morreau, H.; Guchelaar, H.J.; Kapiteijn, E.
- Date
- 2015-12-31